🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary outcome measure is PIRA (progression independent of relapse act...
Status
Recruiting
Location
Northwestern Memorial Hospital
Start Date
2025-11-15
Trial ID
NCT07207148
Treatments Being Tested
This is a randomized, parallel group, double-blind, active-controlled, clin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10
Trial ID
NCT07606521
Treatments Being Tested
This is a double-blind, randomized, active-controlled, parallel group, Phas...
Status
Recruiting
Location
CT-P53 3.1 investigational site
Start Date
2024-01-11
Trial ID
NCT05906992
Treatments Being Tested
The goal of this clinical trial is to learn if drug CYB704, a proposed bios...
Status
Active Not Recruiting
Location
Sandoz Investigational Site
Start Date
2025-06-10
Trial ID
NCT06847724
Treatments Being Tested
The Main objectives of the study are to demonstrate pharmacokinetic (PK) si...
Status
Active Not Recruiting
Location
University of South Alabama
Start Date
2025-01-13
Trial ID
NCT06700343
Treatments Being Tested
REDEFINE-MS is a research study for people with relapsing multiple sclerosi...
Status
Recruiting
Location
Washington University School of Medicine in St. Louis
Start Date
2026-08-15
Trial ID
NCT07758270
Treatments Being Tested